NUCLEIC ACID CONSTRUCT, RECOMBINANT INFLUENZA VIRUS, METHOD FOR PREPARING A RECOMBINANT INFLUENZA VIRUS, COMPOSITION AND USE

The present invention relates to a nucleic acid construct, a recombinant multiply-defective influenza virus, that promotes expression of an immunomodulatory protein in a host. This is applicable to the development of vaccines against infectious diseases, particularly those caused by influenza virus...

Full description

Saved in:
Bibliographic Details
Main Authors XAVIER, Marcelo, Pascoal, MACHADO, Alexandre, de Magalhães, Vieira, PEREIRA, Igor, A, ARAÚJO, Márcio, Sobreira, Silva, ALVES, Pedro Augusto, CARDOSO, Kimberly, Freitas, MESSIAS, Sarah, Giarola, da Silva, FAUSTINO, Lídia Paula, GONÇALVES, Ana Paula, de Faria, DE PAULA, Ianca Évelyn, Silva, TAVARES, Luciana, Pádua, DE CARVALHO, Ketyllen, Reis, Andrade
Format Patent
LanguageEnglish
French
German
Published 19.07.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a nucleic acid construct, a recombinant multiply-defective influenza virus, that promotes expression of an immunomodulatory protein in a host. This is applicable to the development of vaccines against infectious diseases, particularly those caused by influenza virus and Coronavirus.
Bibliography:Application Number: EP20210808722